Published in Clin Microbiol Infect on December 01, 2005
Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med (2009) 8.30
Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect (2011) 2.83
Controlling methicillin-resistant Staphylococcus aureus: quantifying the effects of interventions and rapid diagnostic testing. Proc Natl Acad Sci U S A (2006) 2.75
Are active microbiological surveillance and subsequent isolation needed to prevent the spread of methicillin-resistant Staphylococcus aureus? Clin Infect Dis (2005) 2.47
Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in the Netherlands. J Antimicrob Chemother (2013) 2.21
[Endocarditis due to meticillin-resistant Staphylococcus aureus originating from pigs]. Ned Tijdschr Geneeskd (2006) 2.05
Attitude of Dutch hospital personnel towards influenza vaccination. Vaccine (2008) 2.02
Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clin Infect Dis (2012) 1.79
Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults. Neth J Med (2008) 1.57
[The increase in pneumonia-related morbidity and mortality among adults in the Netherlands and possible explanations for it]. Ned Tijdschr Geneeskd (2004) 1.54
[Missing spleen: indication for pneumococcal vaccination]. Ned Tijdschr Geneeskd (2003) 1.53
Selective decontamination of the oral and digestive tract in surgical versus non-surgical patients in intensive care in a cluster-randomized trial. Br J Surg (2011) 1.46
[Mycobacterium avium infection in HIV-infected patients: epidemiology, diagnosis, prevention and treatment]. Ned Tijdschr Geneeskd (1997) 1.44
Guidelines for severe community-acquired pneumonia in the western world. Neth J Med (1999) 1.44
Transmissibility of livestock-associated methicillin-resistant Staphylococcus aureus (ST398) in Dutch hospitals. Clin Microbiol Infect (2011) 1.42
Comparative in vitro antibacterial activity of sparfloxacin (AT-4140; RP 64206), a new quinolone. Antimicrob Agents Chemother (1991) 1.42
[Increased risk of infection in patients with diabetes mellitus type 1 or 2]. Ned Tijdschr Geneeskd (2006) 1.40
[Diagnosis of hepatic fibrosis and cirrhosis]. Ned Tijdschr Geneeskd (2007) 1.39
[Ventilator-associated pneumonia; controversies with respect to diagnosis, pathogenesis, therapy and prevention]. Ned Tijdschr Geneeskd (1999) 1.38
[Poor results of treatment of echinococcosis with albendazole in 7 patients]. Ned Tijdschr Geneeskd (1994) 1.38
[Causative role of infections with viruses or atypical pathogens in acute exacerbations of chronic bronchitis less frequent than expected]. Ned Tijdschr Geneeskd (1996) 1.38
Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice. Br J Gen Pract (2001) 1.33
Computer-assisted decision support for the diagnosis and treatment of infectious diseases in intensive care units. Lancet Infect Dis (2005) 1.32
Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect Immun (1997) 1.28
Rapid screening of methicillin-resistant Staphylococcus aureus using PCR and chromogenic agar: a prospective study to evaluate costs and effects. Clin Microbiol Infect (2010) 1.25
A double-blind comparison of low-dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis. J Antimicrob Chemother (1990) 1.24
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents (2004) 1.20
Quantitative analysis of phagocytosis and killing of Cryptococcus neoformans by human peripheral blood mononuclear cells by flow cytometry. Clin Diagn Lab Immunol (1995) 1.19
Comparison of the identification of coagulase-negative staphylococci by matrix-assisted laser desorption ionization time-of-flight mass spectrometry and tuf sequencing. Eur J Clin Microbiol Infect Dis (2011) 1.18
Once-daily aminoglycoside administration: new strategies for an old drug. Eur J Clin Microbiol Infect Dis (1989) 1.18
Vancomycin-resistant enterococci: consequences for therapy and infection control. Clin Microbiol Infect (2005) 1.14
Results of a double-blind placebo-controlled study using ciprofloxacin for prevention of travelers' diarrhea. Eur J Clin Microbiol Infect Dis (1989) 1.12
Rapid diagnostic testing of methicillin-resistant Staphylococcus aureus carriage at different anatomical sites: costs and benefits of less extensive screening regimens. Clin Microbiol Infect (2011) 1.11
Identification of genotypically diverse Cryptococcus neoformans and Cryptococcus gattii isolates by Luminex xMAP technology. J Clin Microbiol (2007) 1.10
[Less ventilator-associated pneumonia after oral decontamination with chlorhexidine; a randomised trial]. Ned Tijdschr Geneeskd (2008) 1.08
Observed mortality reduction in patients hospitalized with community-acquired pneumonia may well be confounded by disease severity. Am J Med (2013) 1.07
Immunoglobulin treatment in primary antibody deficiency. Int J Antimicrob Agents (2011) 1.06
Modeling the effects of influenza vaccination of health care workers in hospital departments. Vaccine (2009) 1.06
Clinical relevance of mupirocin resistance in Staphylococcus aureus. J Hosp Infect (2013) 1.06
Symptoms of influenza virus infection in hospitalized patients. Infect Control Hosp Epidemiol (2008) 1.05
[Methicillin-resistant Staphylococcus aureus of livestock origin in Dutch hospitals: high-risk patients need only to be investigated if admitted to hospital]. Ned Tijdschr Geneeskd (2008) 1.03
An algorithm to estimate the importance of bacterial acquisition routes in hospital settings. Am J Epidemiol (2007) 1.01
Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapy. HIV Med (2005) 1.00
Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy. J Antimicrob Chemother (2000) 1.00
Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua. Int J Antimicrob Agents (2004) 0.97
Relative effects of barrier precautions and topical antibiotics on nosocomial bacterial transmission: results of multi-compartment models. Bull Math Biol (2007) 0.97
Prevalence of hospital-acquired infections during successive surveillance surveys conducted at a university hospital in the Netherlands. Infect Control Hosp Epidemiol (2007) 0.96
Reprogramming the host response in bacterial meningitis: how best to improve outcome? Clin Microbiol Rev (2003) 0.95
Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? Clin Microbiol Infect (2010) 0.93
Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia. Clin Microbiol Infect (2006) 0.92
Antibiotic treatment of moderate-severe community-acquired pneumonia: design and rationale of a multicentre cluster-randomised cross-over trial. Neth J Med (2014) 0.92
Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338). Eur J Clin Microbiol Infect Dis (1989) 0.91
Pulmonary surfactant protein A binds to Cryptococcus neoformans without promoting phagocytosis. Eur J Clin Invest (1999) 0.90
Detection of enterococcal surface protein gene (esp) and amplified fragment length polymorphism typing of glycopeptide-resistant Enterococcus faecium during its emergence in a Greek intensive care unit. J Clin Microbiol (2003) 0.89
Cost-effectiveness of targeted screening for hepatitis C in The Netherlands. Epidemiol Infect (2011) 0.89
How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review. J Antimicrob Chemother (2003) 0.88
Acquisition and duration of vancomycin-resistant enterococcal carriage in relation to strain type. J Clin Microbiol (2003) 0.88
Pharmacokinetics of cefepime in patients with respiratory tract infections. Antimicrob Agents Chemother (1990) 0.88
In vivo evidence of impaired peripheral fatty acid trapping in patients with human immunodeficiency virus-associated lipodystrophy. J Clin Endocrinol Metab (2005) 0.87
Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structure. FEMS Immunol Med Microbiol (1999) 0.87
Genotyping and preemptive isolation to control an outbreak of vancomycin-resistant Enterococcus faecium. Clin Infect Dis (2006) 0.86
Psychological impact of short-term isolation measures in hospitalised patients. J Hosp Infect (2010) 0.85
Real-life costs of hepatitis C treatment. Neth J Med (2012) 0.85
The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses. Clin Microbiol Infect (2014) 0.85
Quantitative analysis of phagocytosis of Cryptococcus neoformans by adherent phagocytic cells by fluorescence multi-well plate reader. J Microbiol Methods (2000) 0.85
Algorithm to determine cost savings of targeting antimicrobial therapy based on results of rapid diagnostic testing. J Clin Microbiol (2003) 0.84
Acute hepatitis C virus infection. Euro Surveill (2008) 0.84
Guideline adherence for empirical treatment of pneumonia and patient outcome. Treating pneumonia in the Netherlands. Neth J Med (2013) 0.83
Effect of sub-minimal inhibitory concentrations of ciprofloxacin and fleroxacin on the bacterial capsular antigen and opsonophagocytosis by human polymorphonuclear leukocytes. Zentralbl Bakteriol (1991) 0.83
[Optimisation of the antibiotic policy in the Netherlands. XII. The SWAB guideline for antimicrobial eradication of MRSA in carriers]. Ned Tijdschr Geneeskd (2008) 0.83
Effects of rosiglitazone and metformin on postprandial paraoxonase-1 and monocyte chemoattractant protein-1 in human immunodeficiency virus-infected patients with lipodystrophy. Eur J Pharmacol (2006) 0.83
Double-blind, placebo-controlled study comparing the effect of azithromycin with clarithromycin on oropharyngeal and bowel microflora in volunteers. Eur J Clin Microbiol Infect Dis (2002) 0.82
No interaction between ciprofloxacin and an oral contraceptive. Antimicrob Agents Chemother (1998) 0.82
Clinical impact of a highly prevalent Pseudomonas aeruginosa clone in Dutch cystic fibrosis patients. Clin Microbiol Infect (2010) 0.82
Effects of granulocyte colony-stimulating factor (G-CSF) treatment on granulocyte function and receptor expression in patients with ventilator-dependent pneumonia. Clin Exp Immunol (1998) 0.82
A sequential study of intravenous and oral Fleroxacin for 7 or 14 days in the treatment of complicated urinary tract infections. Int J Antimicrob Agents (1995) 0.82
Isolation rooms for highly infectious diseases: an inventory of capabilities in European countries. J Hosp Infect (2009) 0.82
Comparison of multiple-locus variable-number tandem repeat analysis and pulsed-field gel electrophoresis in a setting of polyclonal endemicity of vancomycin-resistant Enterococcus faecium. Clin Microbiol Infect (2008) 0.82
Disseminated Nocardia asteroides infection complicating renal transplantation. Neth J Med (1987) 0.82
Application of guidelines on preoperative antibiotic prophylaxis in León, Nicaragua. Neth J Med (2006) 0.81
Multiple-dose pharmacokinetic behavior of elvucitabine, a nucleoside reverse transcriptase inhibitor, administered over 21 days with lopinavir-ritonavir in human immunodeficiency virus type 1-infected subjects. Antimicrob Agents Chemother (2008) 0.81
Comparative in vitro antimicrobial activity of carumonam (Ro 17-2301) and its influence on the activity of other antibiotics. Chemotherapy (1987) 0.80
Differences in the antibiotic susceptibility of human Escherichia coli with poultry-associated and non-poultry-associated extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis (2013) 0.80
Multi-centre evaluation of a phenotypic extended spectrum β-lactamase detection guideline in the routine setting. Clin Microbiol Infect (2012) 0.80
Aetiology and resistance patterns of community-acquired pneumonia in León, Nicaragua. Int J Antimicrob Agents (2006) 0.80
Aminoglycoside dosage regimens. Is once a day enough? Clin Pharmacokinet (1993) 0.80
[Community acquired pneumonia; no reason to revise current Dutch antibiotic guidelines]. Ned Tijdschr Geneeskd (2003) 0.79
The influence of subminimal inhibitory concentrations of netilmicin and ceftriaxone on the interaction of Escherichia coli with host defences. J Antimicrob Chemother (1989) 0.79